Showing results (671-680 of 762) with videos related to

Sort By:
Pageof 77
Nature Genetics|July 1, 2008
Identification of renal Cd36 as a determinant of blood pressure and risk for hypertensionMichal Pravenec, Paul C Churchill, Monique C Churchill, et al.
European Urology Focus|July 3, 2026
Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Prostate Biopsy in the Era of Lesion-focused SamplingThibaut Long-Depaquit, Michael Baboudjian, Arthur Peyrottes, et al.
The Journal of Clinical Investigation|October 21, 2015
High salt reduces the activation of IL-4- and IL-13-stimulated macrophagesKatrina J Binger, Matthias Gebhardt, Matthias Heinig, et al.
Investigational New Drugs|May 21, 2017
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase CKhaldoun Almhanna, David Wright, Teresa Macarulla Mercade, et al.
The Lancet. Gastroenterology & Hepatology|June 27, 2017
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trialTim Meyer, Richard Fox, Yuk Ting Ma, et al.
Cardiovascular Research|August 7, 2016
A mutation in the glutamate-rich region of RNA-binding motif protein 20 causes dilated cardiomyopathy through missplicing of titin and impaired Frank-Starling mechanismAbdelaziz Beqqali, Ilse A E Bollen, Torsten B Rasmussen, et al.
Science (New York, N.Y.)|August 29, 2015
HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathyJohn T Hinson, Anant Chopra, Navid Nafissi, et al.
Cancers|April 27, 2024
Chromatin Profiles Are Prognostic of Clinical Response to Bortezomib-Containing Chemotherapy in Pediatric Acute Myeloid Leukemia: Results from the COG AAML1031 TrialAnneke D van Dijk, Fieke W Hoff, Yihua Qiu, et al.
Journal of the American Heart Association|February 19, 2016
Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human DiseaseSperanza Rubattu, Sara Di Castro, Herbert Schulz, et al.
ESMO Open|February 13, 2026
NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trialT Macarulla, R Pazo Cid, M S Womack, et al.
Pageof 77